15 / 43
177
Lu-Dotatate
(n=116)
Octreotide LAR 60mg
(n=113)
Gender
, n (%)
Male
Female
53 (46%)
63 (54%)
60 (53%)
53 (47%)
Age
(years), mean (SD)
63 (±9)
64 (±10)
BMI
(Kg/sqm), mean (SD)
25 (±5)
26 (±7)
Primary tumour site
, n (%)
Jejunum
Ileum
Appendix
Right colon
Other
6 (5%)
86 (74%)
1 (1%)
3 (3%)
20 (17%)
9 (8%)
82 (73%)
2 (2%)
1 (1%)
19 (17%)
Site of metastasis
, n (%)
Liver
Lymph nodes
Bone
Lungs
Other
97 (84%)
77 (66%)
13 (11%)
11 (10%)
40 (35%)
94 (83%)
65 (58%)
12 (11%)
5 (4%)
37 (33%)
Population Characteristics at Enrolment
(ITT population, N=229)
Strosberg et al. N Engl J Med 2017